[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591530":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":23,"locations":29,"responsibleParty":47,"collaborators":12,"id":51,"slug":12,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":52,"sex":58,"minAge":59,"maxAge":12,"enrollmentInfo":60,"targetDuration":12,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":12,"overallStatus":32,"whyStopped":12,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Laval University","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Heparin","NO_INTERVENTION","Standard of care with 70-100 IU\u002Fkg of heparin after a diagnostic only trans-radial catheterization and a dual-artery compression device for hemostasis.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"No heparin","EXPERIMENTAL","No heparin administered after diagnostic only trans-radial catheterization and a dual-artery compression device for hemostasis.",[18],"Other: No heparin",[20],{"type":6,"name":14,"description":21,"armGroupLabels":22,"otherNames":12},"Hemostasis achieved using a dual-artery compression device without administration of heparin after trans-radial diagnostic catheterization",[14],[24],{"name":25,"role":26,"phone":27,"phoneExt":12,"email":28},"Michele Jadin","CONTACT","418-656-8711","michele.jadin@criucpq.ulaval.ca",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"IUCPQ","RECRUITING","Québec","Quebec","G1V4G5","Canada","CA",{"type":39,"coordinates":40},"Point",[41,42],-71.21454,46.81228,{"lat":42,"lon":41},[45],{"name":25,"role":26,"phone":46,"phoneExt":12,"email":28},"4186568711",{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"SPONSOR_INVESTIGATOR","Olivier F. Bertrand","MD","100591530",false,"NCT06981624","Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery Occlusion","Comparaison d'un Traitement systématique à l'héparine Versus sélectif Pour la prévention de l'Occlusion Radiale EASY-Héparine","EASY-Heparin","Inclusion Criteria:\n\n* Any patient referred for a diagnostic transradial catheterism\n\nExclusion Criteria:\n\n* Unable to understand study design or provide informed consent\n* Unable to receive antiplatelet therapy with aspirina and\u002For clopidogrel-prasugrel and\u002For ticagrelor and intravenous anticoagulant derived from heparine or bivalirudine\n* Local condition such as hematoma or pseudo-aneurims precluding radial or ulnar access.\n* Presence of plethysmographic waveform with simultaneous radial and ulnar occlusive compression (due to colaterals or interouseous artery) precluding the evaluation of patent hemostasis.","ALL","18 Years",{"count":61,"type":62},500,"ESTIMATED","INTERVENTIONAL",[65],"NA","Randomized study comparing the systematic use of heparin (standard of care) against an elective use of heparin to prevent radial artery occlusion after a percutaneous catheterization using a dual-artery compression system.",[68],"Radial Artery Occlusion","2026-01-22",{"date":71,"type":72},"2026-01-26","ACTUAL",{"date":74,"type":72},"2025-05-13",{"date":76,"type":62},"2026-12",{"name":49,"class":6},1]